Retatrutide 20

RETA20 | Retatrutide 20mg

Next-generation metabolic research peptide

ImproHealth RETA20 contains 20mg Retatrutide, a research-stage peptide being investigated for its activity at three key metabolic hormone receptors: GLP-1, GIP and glucagon receptors.

This triple-receptor activity has made Retatrutide an important area of metabolic research, particularly in relation to body-weight regulation, appetite, energy balance and glucose metabolism.

Product Details

• Compound: Retatrutide
• Strength: 20mg per vial
• Form: Lyophilised powder
• Brand: ImproHealth
• Product Code: RETA20

Important Information

Retatrutide is an investigational compound and has not been approved as a medicine for general therapeutic use. ImproHealth RETA20 is supplied for research purposes only and is not intended to diagnose, treat, cure or prevent any disease.

ENHANCE. OPTIMISE. THRIVE.